• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.07% Nasdaq Up0.32%

    More On CVD

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Covance Inc. (CVD)

    -NYSE
    106.42 0.00(0.00%) Feb 18, 4:03PM EST
    Add to Portfolio
    CompetitorsGet Competitors for:
    Direct Competitor Comparison 
    CVDCRLPVT1QIndustry
    Market Cap:6.06B3.29BN/A9.23B179.97M
    Employees:N/A7,90011,00032,600139.00
    Qtrly Rev Growth (yoy):N/A-0.01N/A0.040.16
    Revenue (ttm): N/A1.32B1.47B14.23B48.62M
    Gross Margin (ttm):N/A0.38N/A0.360.45
    EBITDA (ttm):N/A290.54MN/A750.69M-1.77M
    Operating Margin (ttm): N/A0.15N/A0.15-0.15
    Net Income (ttm):N/A140.08M123.70M1352.43MN/A
    EPS (ttm):3.232.93N/A2.75N/A
    P/E (ttm):32.9523.99N/A27.3531.12
    PEG (5 yr expected):N/A2.03N/A1.921.37
    P/S (ttm):N/A2.49N/A2.153.76
     
    CRL = Charles River Laboratories International, Inc.
    Pvt1 = PPD DEVELOPMENT, LLC (privately held)
    Q = Quintiles Transnational Holdings Inc.
    Industry = Medical Laboratories & Research
    1 = As of 2010  

     
    News on Direct Competitors 

    Currency in .